![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Global | Publication | November 2016
Welcome to the fourth edition of Corporate and commercial disputes review, in which we examine developments that are likely to affect our corporate clients.
Since the UK’s vote to leave the European Union in June, Brexit has become a key area of interest for companies across all industries. From a disputes perspective, we look at how Brexit could impact upon exclusive jurisdiction clauses, service of process and enforcement of judgments and see why, practically, there is likely to be little material change.
Away from Brexit, we examine several key recent cases, including decisions of the Supreme Court on illegality, retention of title and termination of agency arrangements. We also review two important decisions concerning repudiatory breach and directors’ duties.
In other areas affecting companies, we look at establishing a culture of compliance and the rules governing witness preparation in Germany.
Finally, we consider a recent landmark decision on the recovery of third party funding costs in arbitration and the possible impact for the future of this growing area.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023